A

nd so, another working week will soon draw to a close. Not a moment too soon, yes? This is, as you know, our treasured signal to daydream about weekend plans. Our agenda is particularly modest this time around. We hope to catch up on some reading, tidy up around the castle, and hang with our short person. And what about you? This remains a lovely time of year to enjoy the outdoors, although you may want to winterize your own castle. You could plan a holiday break. Or simply map out the rest of your life. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

The U.S. Securities and Exchange Commission may have told Valeant Pharmaceuticals (VRX) to stop using non-standard earnings numbers in its regulatory filings, but the company is sending journalists the number anyway, MarketWatch reports. The regulator has been cracking down on the use of metrics that do not conform with Generally Accepted Accounted Principles, but that usually make results look better and can be misleading for investors.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.